FADINI, GIAN PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.921
AS - Asia 21.092
EU - Europa 9.841
AF - Africa 3.781
SA - Sud America 3.452
OC - Oceania 372
Continente sconosciuto - Info sul continente non disponibili 164
Totale 76.623
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.928
SG - Singapore 6.592
CN - Cina 3.796
VN - Vietnam 3.025
IT - Italia 2.159
HK - Hong Kong 2.125
BR - Brasile 2.001
FI - Finlandia 855
DE - Germania 785
FR - Francia 781
IN - India 712
BD - Bangladesh 641
SE - Svezia 508
GB - Regno Unito 507
PL - Polonia 452
RU - Federazione Russa 388
IQ - Iraq 359
NL - Olanda 346
AR - Argentina 328
UA - Ucraina 322
TR - Turchia 301
JP - Giappone 271
MX - Messico 242
CA - Canada 232
ZA - Sudafrica 222
PH - Filippine 210
PK - Pakistan 205
SA - Arabia Saudita 190
ID - Indonesia 188
CO - Colombia 181
EC - Ecuador 180
IE - Irlanda 177
ES - Italia 172
BJ - Benin 163
VE - Venezuela 159
UZ - Uzbekistan 149
CI - Costa d'Avorio 148
MA - Marocco 140
AE - Emirati Arabi Uniti 139
MY - Malesia 135
EG - Egitto 131
AT - Austria 125
PE - Perù 125
TN - Tunisia 125
KR - Corea 121
PY - Paraguay 120
AL - Albania 117
AO - Angola 117
CR - Costa Rica 116
DZ - Algeria 115
GR - Grecia 115
JO - Giordania 115
NI - Nicaragua 113
CL - Cile 112
KE - Kenya 112
JM - Giamaica 110
BE - Belgio 109
IL - Israele 108
PA - Panama 108
GA - Gabon 107
TW - Taiwan 104
ET - Etiopia 103
LB - Libano 102
TH - Thailandia 100
PS - Palestinian Territory 99
AZ - Azerbaigian 98
MD - Moldavia 98
CH - Svizzera 97
SN - Senegal 97
KZ - Kazakistan 95
SK - Slovacchia (Repubblica Slovacca) 95
BG - Bulgaria 94
KG - Kirghizistan 94
MK - Macedonia 94
RS - Serbia 94
IR - Iran 93
CZ - Repubblica Ceca 92
LV - Lettonia 92
BO - Bolivia 91
CV - Capo Verde 91
RO - Romania 91
ML - Mali 90
NP - Nepal 90
AM - Armenia 89
TZ - Tanzania 89
UG - Uganda 89
BY - Bielorussia 88
GH - Ghana 88
LA - Repubblica Popolare Democratica del Laos 88
DK - Danimarca 87
EE - Estonia 87
HN - Honduras 87
DO - Repubblica Dominicana 86
PT - Portogallo 86
BA - Bosnia-Erzegovina 85
HU - Ungheria 85
TT - Trinidad e Tobago 85
BZ - Belize 84
MU - Mauritius 84
SO - Somalia 84
Totale 72.400
Salva come PNG Salva come JPEG
Città #
Ashburn 4.549
Fairfield 4.269
Singapore 4.036
San Jose 3.516
Woodbridge 2.552
Houston 2.293
Hong Kong 1.923
Ann Arbor 1.767
Chandler 1.691
Seattle 1.575
Cambridge 1.492
Wilmington 1.342
Ho Chi Minh City 884
Beijing 750
Hanoi 697
Jacksonville 682
Boardman 581
Los Angeles 555
Santa Clara 497
Princeton 462
Helsinki 449
New York 436
San Diego 425
Lauterbourg 366
Roxbury 311
Medford 273
Chicago 264
Padova 252
Guangzhou 250
Bytom 242
Des Moines 235
Council Bluffs 218
The Dalles 203
Munich 202
São Paulo 196
Nanjing 183
Da Nang 179
Tokyo 171
Cotonou 156
Shanghai 151
Milan 147
Dong Ket 146
Dublin 146
Abidjan 140
Baghdad 139
Tashkent 135
Rome 133
Buffalo 132
Orem 130
Warsaw 123
London 113
Frankfurt am Main 108
Libreville 104
Managua 104
Amman 103
Haiphong 103
Denver 102
Dallas 101
Panama City 101
Turku 101
Chennai 94
Luanda 92
Dakar 91
Nairobi 91
Baku 89
Hefei 89
Salt Lake City 89
Kampala 87
Vienna 87
Johannesburg 86
Amsterdam 85
San José 82
Bamako 81
Yerevan 81
Bishkek 80
Addis Ababa 79
Phoenix 79
Lima 77
Nassau 77
Praia 76
Shenyang 76
Vientiane 76
Castries 75
Lahore 75
Nouakchott 75
Harare 74
Istanbul 74
Riga 74
Brooklyn 73
Dearborn 73
Phnom Penh 73
Montreal 72
Conakry 71
Accra 70
Atlanta 69
Djibouti 68
Kigali 68
Quito 68
Tallinn 68
Niamey 67
Totale 46.817
Salva come PNG Salva come JPEG
Nome #
Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence 632
DPP-4 inhibitors moderate the risk of genitourinary tract infections associated with SGLT2 inhibitors 366
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration 356
NETosis delays diabetic wound healing in mice and humans 353
Clinical Efficacy and Safety of Angiogenesis Inhibitors: Sex Differences and Current Challenges 348
Bone marrow macrophages contribute to diabetic stem cell mobilopathy by producing Oncostatin M. 341
Convenience versus Biological Significance: Are PMA-Differentiated THP-1 Cells a Reliable Substitute for Blood-Derived Macrophages When Studying in Vitro Polarization? 338
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 335
Alternative Activation of Human Macrophages Is Rescued by Estrogen Treatment in Vitro and Impaired by Menopausal Status. 326
NETosis is induced by high glucose and associated with type 2 diabetes. 325
Phenotypic activation and pharmacological outcomes of spontaneously differentiated human monocyte-derived macrophages. 323
Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history 322
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients 315
miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways 310
Diabetes-associated myelopoiesis drives stem cell mobilopathy through an OSM-p66Shc signaling pathway 310
Carotid Plaque Calcification Predicts Future Cardiovascular Events in Type 2 Diabetes 306
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study 306
Loss of mitochondrial calcium uniporter rewires skeletal muscle metabolism and substrate preference 305
Acute effects of linagliptin on progenitor cells, monocyte phenotypes, and soluble mediators in type 2 diabetes 304
Circulating Endothelial Progenitor Cells Are Reduced In Peripheral Vascular Complications of Type 2 Diabetes Mellitus 302
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 302
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 298
Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients. 296
Mitochondrial Calcium Uptake Is Instrumental to Alternative Macrophage Polarization and Phagocytic Activity 293
A perspective on NETosis in diabetes and cardiometabolic disorders 290
The continuum of monocyte phenotypes: Experimental evidence and prognostic utility in assessing cardiovascular risk 290
Non-genomic mechanisms in the estrogen regulation of glycolytic protein levels in endothelial cells 286
Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes 285
Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trial 285
Performance of the Steno type 1 risk engine for cardiovascular disease prediction in Italian patients with type 1 diabetes 284
Lung Ultrasound Patterns and Clinical-Laboratory Correlates during COVID-19 Pneumonia: A Retrospective Study from North East Italy 284
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine. 282
Arrhythmogenic Cardiomyopathy Is a Multicellular Disease Affecting Cardiac and Bone Marrow Mesenchymal Stromal Cells 282
Clones of Interstitial Cells From Bovine Aortic Valve Exhibit Different Calcifying Potential When Exposed to Endotoxin and Phosphate 280
Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs. 280
Diabetes Limits Stem Cell Mobilization Following G-CSF but not Plerixafor. 279
p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans 278
Cross-talk of healthy and impaired human tissues for dissection of disease pathogenesis 275
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 271
Sarcoidosis is a Th1/Th17 multisystem disorder 268
The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo 268
Inhibition of SGLT-2 rescues bone marrow cell traffic for vascular repair. Role of glucose control and ketogenesis 266
Development of a multiphoton-multicolor and super-resolution STED microscope for in vivo experiments 265
A view on the quality of diabetes care in Italy and the role of Diabetes Clinics from the 2018 ARNO Diabetes Observatory 265
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial 264
Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study 263
A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. 262
Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes 262
The peritoneum as a natural scaffold for vascular regeneration. 260
An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. 260
High temporal resolution detection of patient-specific glucose uptake from human ex vivo adipose tissue on-chip. 258
The impact of clinical history on the predictive performance of machine learning and deep learning models for renal complications of diabetes 256
Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial. 256
High Abundance Proteins Depletion vs Low Abundance Proteins Enrichment: Comparison of Methods to Reduce the Plasma Proteome Complexity 256
17beta-estradiol modulates monocyte heterogeneity and macrophage polarization 254
Circulating myeloid calcifying cells have anti-angiogenic activity via thrombospondin-1 overexpression 254
Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications 254
Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans. 253
Atorvastatin Reduces Circulating Osteoprogenitor Cells and T-Cell RANKL Expression in Osteoporotic Women: Implications for the Bone-Vascular Axis 253
Explainable Deep-Learning Model Reveals Past Cardiovascular Disease in Patients with Diabetes Using Free-Form Visit Reports 251
Downregulation of the Longevity-Associated Protein SIRT1 in Insulin Resistance and Metabolic Syndrome. Potential Biochemical Mechanisms 251
Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. 249
Effects of Hypoglycemia on Circulating Stem and Progenitor Cells in Diabetic Patients 249
Use and effectiveness of dapagliflozin in routine clinical practice. An Italian multicenter retrospective study 249
Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study 248
Hematopoietic and Nonhematopoietic p66Shc Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes 248
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study 246
Bisdemethoxycurcumin and Its Cyclized Pyrazole Analogue Differentially Disrupt Lipopolysaccharide Signalling in Human Monocyte-Derived Macrophages 245
Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells 244
Insulin-induced glucose control improves HDL cholesterol levels but not reverse cholesterol transport in type 2 diabetic patients. 243
Interplay between gut microbiota and p66Shc affects obesity-associated insulin resistance 243
Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes 241
Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia 239
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study 238
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. 237
Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients 236
Impaired endothelial progenitor cell recruitment may contribute to heart transplant microvasculopathy. 235
Circulating Stem Cells Associate With Adiposity and Future Metabolic Deterioration in Healthy Subjects 231
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study 231
Effects of glucose variability on hematopoietic stem/progenitor cells in patients with type 1 diabetes 230
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker. 229
Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. 229
Characteristics, prevalence, and outcomes of diabetic foot ulcers in Africa. A systemic review and meta-analysis 228
Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine care 226
Effects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: A case-control study 225
Monocyte-macrophage polarization balance in pre-diabetic individuals. 225
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. 224
Peripheral blood CD34(+)KDR(+) endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population 224
Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures 224
Cardiovascular actions of GLP-1 and incretin-based pharmacotherapy. 223
Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study 223
An underlying principle for the study of circulating progenitor cells in diabetes and its complications. 222
Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice 222
Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1 221
Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis. 221
Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs 221
Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. 219
Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy. 219
The rs2274911 polymorphism in GPRC6A gene is associated with insulin resistance in normal weight and obese subjects 218
Circulating CD34(+) cells, metabolic syndrome, and cardiovascular risk 217
Totale 26.984
Salva come PNG Salva come JPEG
Categoria #
all - tutte 215.794
article - articoli 204.269
book - libri 1.088
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 458
Totale 421.609
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021600 0 0 0 0 0 0 0 0 0 0 0 600
2021/20225.288 203 550 698 329 282 324 252 590 318 123 511 1.108
2022/20233.485 745 373 75 452 489 433 38 250 415 42 142 31
2023/20242.057 79 293 234 146 111 218 159 77 86 242 201 211
2024/20258.643 23 579 380 319 992 265 539 663 808 405 1.469 2.201
2025/202640.525 1.672 2.999 5.389 6.957 3.927 1.814 5.282 3.421 4.477 2.424 1.948 215
Totale 77.161